Pharma Mar S.A. (PHM) — Net Asset Momentum
Pharma Mar S.A. (PHM) recorded a net asset momentum of 20.9% as of December 2025, with net assets of €251.83 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Pharma Mar S.A. to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Pharma Mar S.A. Net Asset Momentum (2002–2025)
This chart tracks Pharma Mar S.A.'s year-over-year net asset growth across 24 annual reporting periods from 2002 to 2025. The most recent momentum reading is +20.9%, with net assets of €251.83 Million EUR as of December 2025. Read Pharma Mar S.A. (PHM) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Pharma Mar S.A. (2002–2025)
The table below shows the complete annual net asset history for Pharma Mar S.A. from 2002 to 2025, covering 24 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PHM market cap.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €251.83 Million | €395.08 Million | €143.25 Million | ▲ +20.9% |
| 2024 | €208.36 Million | €349.64 Million | €141.28 Million | ▲ +7.7% |
| 2023 | €193.44 Million | €340.52 Million | €147.08 Million | ▼ -13.2% |
| 2022 | €222.96 Million | €393.26 Million | €170.30 Million | ▲ +25.3% |
| 2021 | €177.92 Million | €368.39 Million | €190.47 Million | ▲ +73.2% |
| 2020 | €102.72 Million | €330.26 Million | €227.54 Million | ▲ +1277.7% |
| 2019 | €7.46 Million | €124.70 Million | €117.25 Million | ▼ -57.3% |
| 2018 | €17.47 Million | €157.68 Million | €140.20 Million | ▼ -24.0% |
| 2017 | €22.98 Million | €187.72 Million | €164.74 Million | ▼ -52.6% |
| 2016 | €48.49 Million | €221.14 Million | €172.64 Million | ▼ -33.6% |
| 2015 | €73.04 Million | €211.94 Million | €138.90 Million | ▲ +21.6% |
| 2014 | €60.07 Million | €201.39 Million | €141.32 Million | ▲ +21.5% |
| 2013 | €49.44 Million | €189.37 Million | €139.94 Million | ▲ +27.7% |
| 2012 | €38.73 Million | €199.83 Million | €161.10 Million | ▲ +12.2% |
| 2011 | €34.50 Million | €217.82 Million | €183.31 Million | ▼ -1.0% |
| 2010 | €34.86 Million | €230.82 Million | €195.96 Million | ▼ -15.3% |
| 2009 | €41.14 Million | €211.31 Million | €170.18 Million | ▼ -16.6% |
| 2008 | €49.34 Million | €207.54 Million | €158.20 Million | ▼ -50.1% |
| 2007 | €98.81 Million | €232.33 Million | €133.51 Million | ▼ -7.8% |
| 2006 | €107.17 Million | €224.41 Million | €117.23 Million | ▼ -70.2% |
| 2005 | €360.04 Million | €393.72 Million | €33.68 Million | ▲ +19.5% |
| 2004 | €301.23 Million | €337.34 Million | €36.11 Million | ▲ +116.3% |
| 2003 | €139.28 Million | €275.47 Million | €136.20 Million | ▼ -16.6% |
| 2002 | €166.90 Million | €271.43 Million | €104.53 Million | — |